Procaine Hydrochloride CAS 51-05-8 is the water-soluble hydrochloride salt of procaine. It is the specific formulation used in clinical medicine, famously marketed under the brand name Novocain. While its use in mainstream practice has diminished, it remains a historically pivotal drug and is still employed in specific medical and therapeutic contexts.
Name :
Procaine hydrochlorideCAS No. :
51-05-8MF :
C₁₃H₂₁ClN₂O₂MW :
272.77Purity :
98%Appearance :
White crystalline powderStorage Condition :
Stored in a cool, dry place away from lightChemical Properties
Chemical Name: 2-(Diethylamino)ethyl 4-aminobenzoate hydrochloride
IUPAC Name: 4-Aminobenzoic acid 2-(diethylamino)ethyl ester; hydrochloride
CAS Number: 51-05-8
Molecular Formula: C₁₃H₂₁ClN₂O₂
Molecular Weight: 272.77 g/mol
Chemical Structure: It consists of a procaine molecule (a benzoic acid ester with a terminal diethylamino group) in a salt formation with hydrochloric acid, resulting in a positively charged ammonium ion and a chloride counterion. This salt form is crucial for its solubility and stability in aqueous pharmaceutical preparations.
Appearance: A white, crystalline powder or colorless crystals.
Solubility: Very soluble in water, freely soluble in ethanol. The salt formation dramatically increases its water solubility compared to the procaine free base, making it suitable for injection.
Stability:
Stable in dry form and in acidic solutions (pH ~3.5-5.0 for injections).
The ester bond remains its primary site of instability. It undergoes hydrolysis in neutral or alkaline solutions, accelerated by heat, producing para-aminobenzoic acid (PABA) and diethylaminoethanol.
Solutions should be sterilized by methods that minimize heat exposure (e.g., filtration) and stored protected from light.
pKa: ~8.9 (of the conjugate acid). At physiological pH (7.4), a significant portion exists in the lipid-soluble, uncharged base form, allowing diffusion through nerve sheaths, while the charged cationic form is active at the sodium channel receptor.
Biological Activities
Mechanism of Action: Reversible sodium channel blocker. It diffuses to the neural membrane, and its cationic form binds to receptors within voltage-gated sodium channels, inhibiting sodium ion influx and preventing depolarization and propagation of the action potential, leading to a reversible loss of sensation.
Pharmacokinetics:
Onset: Relatively slow onset of action compared to modern agents like lidocaine.
Duration: Short duration (30-60 minutes for infiltration anesthesia) due to rapid hydrolysis by plasma pseudocholinesterase and significant vasodilation at the site of injection, which increases vascular absorption and removal.
Metabolism: Rapidly hydrolyzed in the plasma by esterases into the metabolites PABA (a known allergen) and diethylaminoethanol.
Toxicity Profile: Lower systemic toxicity than cocaine. Adverse effects (CNS: dizziness, tremors; Cardiovascular: hypotension) are usually associated with high plasma concentrations from intravascular injection or overdose. Allergic reactions, though rare, are primarily linked to sensitivity to PABA or other ester anesthetics.
Biosynthesis
Procaine hydrochloride is not biosynthesized; it is produced via chemical synthesis.
The standard industrial synthesis involves:
1.Esterification: Reaction of 4-aminobenzoic acid (PABA) with ethylene chlorohydrin (2-chloroethanol) to form the ester intermediate, 4-aminobenzoic acid 2-chloroethyl ester.
2.Amination: The chloro-intermediate is then reacted with diethylamine to form procaine free base.
3.Salt Formation: The procaine base is finally treated with hydrochloric acid to precipitate the stable, water-soluble procaine hydrochloride.
Applications
FAQs
Q1: What is the key difference between Procaine (CAS 59-46-1) and Procaine Hydrochloride (CAS 51-05-8)?
A1: Procaine is the free base, a lipophilic compound with limited water solubility. Procaine Hydrochloride is the water-soluble hydrochloride salt of procaine. This salt form is what is used in all injectable pharmaceutical formulations. The CAS numbers are different, confirming they are distinct chemical entities for regulatory and sourcing purposes.
Q2: Is Procaine HCl (Novocain) still commonly used by dentists?
A2: In most developed countries, its use in mainstream dentistry has been largely superseded by amide-type anesthetics like lidocaine, articaine, and mepivacaine. These newer agents have a faster onset, longer duration, and a lower incidence of allergic reactions. It may still be used in specific cases or regions.
Q3: Why is there an allergy warning associated with "caine" drugs, and does it apply to procaine?
A3: True allergy to local anesthetics is rare. However, ester-type anesthetics like procaine are metabolized to PABA. Allergic reactions (like dermatitis or anaphylaxis) are more likely due to sensitivity to PABA or the ester structure itself. Amide-type anesthetics (lidocaine, etc.) do not produce PABA and have no cross-reactivity with esters, making them safer for patients with known ester allergies.
Q4: Why is epinephrine often added to procaine HCl solutions?
A4: Procaine is a vasodilator, increasing local blood flow and causing it to be absorbed into the bloodstream too quickly. Epinephrine, a vasoconstrictor, is added to:
Prolong the anesthetic effect by reducing local blood flow.
Lower the systemic concentration of procaine, reducing the risk of toxicity.
Provide a bloodless field for surgery.
Q5: Can I purchase Procaine Hydrochloride (CAS 51-05-8) for research purposes?
A5: Yes, it is readily available from reputable chemical and biochemical suppliers for legitimate research and development use. Buyers must confirm they are compliant with all local regulations. It is sold as a chemical or pharmaceutical reference standard, not for human or veterinary therapeutic use unless appropriately licensed and formulated.
Q6: What are the main disadvantages that led to its reduced use?
A6: Key limitations include: 1) Short duration of action, 2) Slower onset compared to amides, 3) Potential for allergic reactions (PABA-related), 4) Vasodilatory property, requiring adjuncts like epinephrine, and 5) The development of superior alternatives (amides) with better pharmacokinetic profiles.
Procaine Hydrochloride CAS 51-05-8 is the water-soluble hydrochloride salt of procaine. It is the specific formulation used in clinical medicine, famously marketed under the brand name Novocain. While its use in mainstream practice has diminished, it remains a historically pivotal drug and is still employed in specific medical and therapeutic contexts.
Details
3-Butoxyphenol CAS 18979-72-1 is a synthetic aromatic ether and a monoalkyl ether derivative of resorcinol (1,3-dihydroxybenzene). Its structure consists of a phenol ring with a hydroxyl group (-OH) and a butoxy group (-O-CH₂-CH₂-CH₂-CH₃) both attached in a meta relationship to each other (positions 1 and 3).3-Butoxyphenol is a bifunctional meta-substituted phenolic ether that uniquely combines the antioxidant and reactive properties of a phenol with the solubilizing power and stability of an alkyl ether. This makes it an exceptional synergistic stabilizer and versatile chemical building block for performance-critical formulations.
Details
Diethyl malate CAS 7554-12-3 is the diethyl ester of malic acid, a naturally occurring dicarboxylic acid. It is a clear, colorless to pale yellow liquid ester with a characteristic, mild fruity odor. Its structure consists of a four-carbon malate backbone (HOOC-CH2-CH(OH)-COOH) where both carboxylic acid groups are esterified with ethanol.Diethyl Malate is a multifunctional, bio-based ester that uniquely serves as a high-performance green solvent, a pleasant flavor/fragrance precursor, and a versatile chemical building block. Its combination of safety, sustainability, and dual functional group reactivity makes it a superior choice for modern, eco-conscious formulations.
Details
(R)-3-(1-Methyl-2-pyrrolidinyl)pyridine CAS 25162-00-9 is the dextrorotatory (R)-enantiomer of nicotine, the principal alkaloid found in plants of the Nicotianagenus. Its structure consists of a pyridine ring linked to an N-methylpyrrolidine ring, with a stereogenic center at the 2'-position of the pyrrolidine ring.This compound is enantiomerically pure, natural-configuration (R)-(−)-Nicotine. Its value is defined by its specific, high-affinity interaction with nicotinic acetylcholine receptors (nAChRs), making it the gold-standard ligand and active ingredient for research and precision applications where stereochemical purity is non-negotiable for biological activity and regulatory compliance.
Details
p-Chlorophenethyl bromide CAS 6529-53-9 is a halogenated organic compound belonging to the class of arylalkyl bromides. It consists of a phenethyl group (a benzene ring with a two-carbon ethylene spacer) substituted with a chlorine atom at the paraposition and a bromine atom on the terminal carbon of the ethylene chain. This structure makes it a valuable electrophilic alkylating agent and a versatile bifunctional building block in synthetic organic chemistry.p-Chlorophenethyl Bromide is a bifunctional and chemoselective synthetic building block designed for efficient, multi-step molecular construction. Its structure provides two distinct and orthogonally reactive sites—a highly reactive primary bromide and a stable aryl chloride—enabling sequential, controlled derivatization that is fundamental to modern organic synthesis, particularly in pharmaceutical discovery.
Details
Methyl 4-(1-piperazinyl)benzoate CAS 163210-97-7 is a synthetic organic compound belonging to the class of piperazine-containing benzoate esters. It consists of a benzoate ester core (methyl para-aminobenzoate derivative) where the amino group is part of a piperazine ring. This structure makes it a versatile pharmacophore and key synthetic intermediate.Methyl 4-(1-piperazinyl)benzoate is a privileged pharmaceutical building block that combines a synthetically versatile benzoate ester with a piperazine ring—a ubiquitous pharmacophore in CNS-active drugs. Its primary advantage lies in being the definitive, high-value intermediate in the synthesis of blockbuster antipsychotics, while also serving as a versatile scaffold for novel drug discovery.
Details
N-Ethoxycarbonylcarbamic Acid Ethyl Ester CAS 19617-44-8 is a versatile and efficient symmetrical diethyl dicarbonate reagent primarily used as a compact, mild protecting group agent and heterocyclic building block in organic synthesis.
Details
(S)-(−)-Tetrahydro-2-furoic acid CAS 87392-07-2 is a chiral, non-proteinogenic carboxylic acid featuring a saturated furan ring (tetrahydrofuran, THF) with a carboxylic acid group at the 2-position. It is the single (S)-enantiomer of 2-tetrahydrofuroic acid, a valuable chiral building block in organic synthesis. This compound is a high-value, enantiomerically pure chiral building block that provides a ready-to-use, metabolically stable, and conformationally constrained tetrahydrofuran (THF) carboxylic acid scaffold in the (S)-configuration. Its primary value lies in enabling efficient, stereocontrolled synthesis of complex molecules for life sciences.
Details
Contact Us
1st Floor, No. 477, Huancheng West Road, Nanqiao Town, Fengxian District, Shanghai,China
sales@qxscientific.com
+86 -13701740203
IPv6 Network Supported |
Sitemap |
XML |
Blog |
Privacy Policy
Leave A Message
Scan to Wechat/Whatsapp :
English
English
Español
Português
